{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T03:31:36Z","timestamp":1782703896562,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cervical cancer shows great differences in depth of invasion, metastasis, and other biological behaviors. The location of the lesion is special, so it is usually difficult to determine the clinical stage. This study aimed to explore the clinical value of magnetic resonance imaging (MRI) and tumor serum markers for the preoperative diagnosis of cervical cancer lymph node metastasis and para-uterine invasion.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 200 patients with cervical cancer admitted to our hospital from January 2019 to January 2020 were collected as the research subjects. Comparing the diagnosis results of preoperative MRI scan, serum tumor markers, and postoperative pathological examination using single factor comparison, we determined the MRI scan results, the comprehensive matching rate between serum tumor markers (squamous cell carcinoma antigen (SCCA), carbohydrate antigen 125 (CA125)) and postoperative pathological results, and the differences of sensitivity, specificity, and accuracy in the prediction of lymph node metastasis and para-uterine infiltration of cervical cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The levels of SCCA and CA125 in patients with para-uterine invasion and lymph node metastasis were higher than those of patients without invasion and metastasis. Among them, the level of SCCA was significantly different (<jats:italic>P<\/jats:italic>&lt;0.05). The level of CA125 was not statistically significant (<jats:italic>P<\/jats:italic>&gt;0.05), so MRI combined with serum SCCA was selected for combined diagnosis in the later period. The sensitivity, specificity, and accuracy of MRI diagnosis of cervical cancer and para-uterine infiltrating lymph node metastasis and metastasis were 55.2, 91.6, and 89.5% and 55.2, 91.6, and 89.5%, respectively. These data in MRI combined with serum SCCA were 76.3, 95.3, and 94.3% and 63.2, 96.0, and 95.1%, respectively. The accuracy of tumor markers combined with MRI in the diagnosis of cervical cancer lymph node metastasis and para-uterine invasion was higher than that of MRI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>MRI combined with serum SCCA can more accurately identify cervical cancer lymph node metastasis and para-uterine invasion compared with MRI alone. Tumor marker combined with MRI diagnosis is an important auxiliary method for cervical cancer treatment and can provide comprehensive and reliable clinical evidence for evaluation before cervical cancer surgery.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12957-021-02448-3","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T07:02:56Z","timestamp":1639033376000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Clinical value of MRI, serum SCCA, and CA125 levels in the diagnosis of lymph node metastasis and para-uterine infiltration in cervical cancer"],"prefix":"10.1186","volume":"19","author":[{"given":"Chao","family":"Ran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhui","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,9]]},"reference":[{"key":"2448_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7\u201330.","journal-title":"CA Cancer J Clin."},{"issue":"Suppl 10","key":"2448_CR2","doi-asserted-by":"publisher","first-page":"K29","DOI":"10.1016\/j.vaccine.2008.06.019","volume":"26","author":"J Cuzick","year":"2008","unstructured":"Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine. 2008;26(Suppl 10):K29\u201341.","journal-title":"Vaccine."},{"key":"2448_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115\u201332.","journal-title":"CA Cancer J Clin."},{"key":"2448_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87\u2013108.","journal-title":"CA Cancer J Clin."},{"key":"2448_CR5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3390\/diagnostics11020202","volume":"11","author":"H Tsuyoshi","year":"2021","unstructured":"Tsuyoshi H, Tsujikawa T, Yamada S, Okazawa H, Yoshida Y. Diagnostic value of 18F-FDG PET\/MRI for revised 2018 FIGO staging in patients with cervical cancer. Diagnostics. 2021;11:202.","journal-title":"Diagnostics."},{"issue":"Suppl 2","key":"2448_CR6","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1016\/j.ijgo.2015.06.004","volume":"131","author":"A Bermudez","year":"2015","unstructured":"Bermudez A, Bhatla N, Leung E. Cancer of the cervix uteri. Int J Gynaecol Obstet. 2015;131(Suppl 2):S88\u201395.","journal-title":"Int J Gynaecol Obstet."},{"key":"2448_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000453666","volume":"92","author":"AT Tsunoda","year":"2017","unstructured":"Tsunoda AT, Marnitz S, Soares Nunes J, Mattos de Cunha Andrade CE, Scapulatempo Neto C, Blohmer JU, et al. Incidence of histologically proven pelvic and para-aortic lymph node metastases and rate of upstaging in patients with locally advanced cervical cancer: results of a prospective randomized trial. Oncology. 2017;92:213\u201320.","journal-title":"Oncology."},{"key":"2448_CR8","doi-asserted-by":"publisher","first-page":"5951","DOI":"10.7314\/APJCP.2015.16.14.5951","volume":"16","author":"I Ruengkhachorn","year":"2015","unstructured":"Ruengkhachorn I, Therasakvichya S, Warnnissorn M, Leelaphatanadit C, Sangkarat S, Srisombat J. Pathologic risk factors and oncologic outcomes in early-stage cervical cancer patients treated by radical hysterectomy and pelvic lymphadenectomy at a Thai University Hospital: a 7 year retrospective review. Asian Pac J Cancer Prev. 2015;16:5951\u20136.","journal-title":"Asian Pac J Cancer Prev."},{"key":"2448_CR9","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1245\/s10434-017-5917-0","volume":"24","author":"G Ferrandina","year":"2017","unstructured":"Ferrandina G, Pedone Anchora L, Gallotta V, Fagotti A, Vizza E, Chiantera V, et al. Can we define the risk of lymph node metastasis in early-stage cervical cancer patients? A Large-Scale, Retrospective Study. Ann Surg Oncol. 2017;24:2311\u20138.","journal-title":"Ann Surg Oncol."},{"key":"2448_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ejso.2012.10.011","volume":"39","author":"A Achouri","year":"2013","unstructured":"Achouri A, Huchon C, Bats AS, Bensaid C, Nos C, L\u00e9curu F. Complications of lymphadenectomy for gynecologic cancer. Eur J Surg Oncol. 2013;39:81\u20136.","journal-title":"Eur J Surg Oncol."},{"key":"2448_CR11","doi-asserted-by":"publisher","first-page":"516","DOI":"10.4143\/crt.2019.328","volume":"52","author":"SY Jeong","year":"2020","unstructured":"Jeong SY, Park H, Kim MS, Kang JH, Paik ES, Lee YY, et al. Pretreatment lymph node metastasis as a prognostic significance in cervical cancer: comparison between disease status. Cancer Res Treat. 2020;52:516\u201323.","journal-title":"Cancer Res Treat."},{"issue":"Suppl 6","key":"2448_CR12","doi-asserted-by":"publisher","first-page":"vi35","DOI":"10.1093\/annonc\/mdr374","volume":"22","author":"N Colombo","year":"2011","unstructured":"Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, et al. Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2011;22(Suppl 6):vi35\u20139.","journal-title":"Ann Oncol."},{"key":"2448_CR13","doi-asserted-by":"publisher","first-page":"348","DOI":"10.11152\/mu-1493","volume":"20","author":"N Yildirim","year":"2018","unstructured":"Yildirim N, Saatli B, Kose S, Sancar C, Ulukus C, Koyuncuoglu M, et al. Predictability of myometrial, lower uterine segment and cervical invasion with 3D transvaginal ultrasonography and magnetic resonance imaging in endometrial cancer patients: a prospective cohort study. Med Ultrason. 2018;20:348\u201354.","journal-title":"Med Ultrason."},{"key":"2448_CR14","first-page":"700","volume":"19","author":"L Luo","year":"2020","unstructured":"Luo L, Luo Q, Tang L. Diagnostic value and clinical significance of MRI and CT in detecting lymph node metastasis of early cervical cancer. Oncol Lett. 2020;19:700\u20136.","journal-title":"Oncol Lett."},{"key":"2448_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.crad.2011.02.018","volume":"67","author":"IS Haldorsen","year":"2012","unstructured":"Haldorsen IS, Salvesen HB. Staging of endometrial carcinomas with MRI using traditional and novel MRI techniques. Clin Radiol. 2012;67:2\u201312.","journal-title":"Clin Radiol."},{"key":"2448_CR16","doi-asserted-by":"publisher","first-page":"614008","DOI":"10.3389\/fonc.2020.614008","volume":"10","author":"P Decazes","year":"2021","unstructured":"Decazes P, Hinault P, Veresezan O, Thureau S, Gouel P, Vera P. Trimodality PET\/CT\/MRI and radiotherapy: a mini-review. Front Oncol. 2021;10:614008.","journal-title":"Front Oncol."},{"key":"2448_CR17","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.3389\/fonc.2020.01393","volume":"10","author":"L Hou","year":"2020","unstructured":"Hou L, Zhou W, Ren J, Du X, Xin L, Zhao X, et al. Radiomics analysis of multiparametric MRI for the preoperative prediction of lymph node metastasis in cervical cancer. Front Oncol. 2020;10:1393.","journal-title":"Front Oncol."},{"key":"2448_CR18","doi-asserted-by":"publisher","first-page":"6938","DOI":"10.1007\/s00330-021-07735-x","volume":"31","author":"J Song","year":"2021","unstructured":"Song J, Hu Q, Ma Z, Zhao M, Chen T, Shi H. Feasibility of T2WI-MRI-based radiomics nomogram for predicting normal-sized pelvic lymph node metastasis in cervical cancer patients. Eur Radiol. 2021;31:6938\u201348.","journal-title":"Eur Radiol."},{"key":"2448_CR19","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1007\/s00261-019-01984-7","volume":"44","author":"P Balcacer","year":"2019","unstructured":"Balcacer P, Shergill A, Litkouhi B. MRI of cervical cancer with a surgical perspective: staging, prognostic implications and pitfalls. Abdom Radiol (NY). 2019;44:2557\u201371.","journal-title":"Abdom Radiol (NY)."},{"key":"2448_CR20","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1111\/j.1349-7006.2010.01532.x","volume":"101","author":"HJ Choi","year":"2010","unstructured":"Choi HJ, Ju W, Myung SK, Kim Y. Diagnostic performance of computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography\/computer tomography for detection of metastatic lymph nodes in patients with cervical cancer: meta-analysis. Cancer Sci. 2010;101:1471\u20139.","journal-title":"Cancer Sci."},{"key":"2448_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1159\/000441784","volume":"81","author":"SC Liu","year":"2016","unstructured":"Liu SC, Huang EY, Hu CF, Ou YC, ChangChien CC, Wang CJ, et al. Pretreatment factors associated with recurrence for patients with cervical cancer international federation of gynecology and obstetrics stage IB1 disease. Gynecol Obstet Invest. 2016;81:339\u201345.","journal-title":"Gynecol Obstet Invest."},{"key":"2448_CR22","doi-asserted-by":"publisher","first-page":"689","DOI":"10.4103\/jcrt.JCRT_414_17","volume":"13","author":"S Guo","year":"2017","unstructured":"Guo S, Yang B, Liu H, Li Y, Li S, Ma L, et al. Serum expression level of squamous cell carcinoma antigen, highly sensitive C-reactive protein, and CA-125 as potential biomarkers for recurrence of cervical cancer. J Cancer Res Ther. 2017;13:689\u201392.","journal-title":"J Cancer Res Ther."},{"key":"2448_CR23","first-page":"177","volume":"9","author":"N Zamani","year":"2015","unstructured":"Zamani N, Modares Gilani M, Zamani F, Zamani MH. Utility of pelvic MRI and tumor markers HE4 and CA125 to predict depth of myometrial invasion and cervical involvement in endometrial cancer. J Family Reprod Health. 2015;9:177\u201383.","journal-title":"J Family Reprod Health."},{"key":"2448_CR24","doi-asserted-by":"publisher","first-page":"e0149687","DOI":"10.1371\/journal.pone.0149687","volume":"11","author":"EF Attia","year":"2016","unstructured":"Attia EF, Jolley SE, Crothers K, Schnapp LM, Liles WC. Soluble vascular cell adhesion molecule-1 (sVCAM-1) is elevated in bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome. PLoS One. 2016;11:e0149687.","journal-title":"PLoS One."},{"key":"2448_CR25","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ana.24083","volume":"75","author":"T Armangue","year":"2014","unstructured":"Armangue T, Leypoldt F, M\u00e1laga I, Raspall-Chaure M, Marti I, Nichter C, et al. Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol. 2014;75:317\u201323.","journal-title":"Ann Neurol."},{"key":"2448_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cld.2015.01.001","volume":"19","author":"KA McGlynn","year":"2015","unstructured":"McGlynn KA, Petrick JL, London WT. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clin Liver Dis. 2015;19:223\u201338.","journal-title":"Clin Liver Dis."},{"key":"2448_CR27","first-page":"5079","volume":"37","author":"C Th\u00e9odore","year":"2017","unstructured":"Th\u00e9odore C, Levaillant JM, Capmas P, Chabi N, Skalli D, Vienet-Legu\u00e9 L, et al. MRI and ultrasound fusion imaging for cervical cancer. Anticancer Res. 2017;37:5079\u201385.","journal-title":"Anticancer Res."},{"key":"2448_CR28","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.brachy.2016.01.002","volume":"15","author":"LM Tait","year":"2016","unstructured":"Tait LM, Hoffman D, Benedict S, Valicenti R, Mayadev JS. The use of MRI deformable image registration for CT-based brachytherapy in locally advanced cervical cancer. Brachytherapy. 2016;15:333\u201340.","journal-title":"Brachytherapy."},{"key":"2448_CR29","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1080\/14789450.2016.1210514","volume":"13","author":"G Kontostathi","year":"2016","unstructured":"Kontostathi G, Zoidakis J, Anagnou NP, Pappa KI, Vlahou A, Makridakis M. Proteomics approaches in cervical cancer: focus on the discovery of biomarkers for diagnosis and drug treatment monitoring. Expert Rev Proteomics. 2016;13:731\u201345.","journal-title":"Expert Rev Proteomics."},{"key":"2448_CR30","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1373\/clinchem.2009.133124","volume":"56","author":"CM Sturgeon","year":"2010","unstructured":"Sturgeon CM, Duffy MJ, Hofmann BR, Lamerz R, Fritsche HA, Gaarenstroom K, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers. Clin Chem. 2010;56:e1\u2013e48.","journal-title":"Clin Chem."},{"key":"2448_CR31","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1002\/ijc.29185","volume":"136","author":"A Sasaki","year":"2015","unstructured":"Sasaki A, Akita K, Ito F, Mori T, Kitawaki J, Nakada H. Difference in mesothelin-binding ability of serum CA125 between patients with endometriosis and epithelial ovarian cancer. Int J Cancer. 2015;136:1985\u201390.","journal-title":"Int J Cancer."},{"key":"2448_CR32","doi-asserted-by":"publisher","first-page":"4995","DOI":"10.1021\/pr500601w","volume":"13","author":"AP Boichenko","year":"2014","unstructured":"Boichenko AP, Govorukhina N, Klip HG, van der Zee AG, G\u00fczel C, Luider TM, et al. A panel of regulated proteins in serum from patients with cervical intraepithelial neoplasia and cervical cancer. J Proteome Res. 2014;13:4995\u20135007.","journal-title":"J Proteome Res."},{"key":"2448_CR33","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.3802\/jgo.2019.30.e1","volume":"30","author":"KH Choi","year":"2019","unstructured":"Choi KH, Lee SW, Yu M, Jeong S, Lee JW, Lee JH. Significance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive chemoradiotherapy: a multi-institutional analysis. J Gynecol Oncol. 2019;30:e1.","journal-title":"J Gynecol Oncol."},{"key":"2448_CR34","first-page":"479","volume":"39","author":"H Zou","year":"2021","unstructured":"Zou H, Zhou Y. Diagnostic value of CT combined with high resolution pelvic MRI in colorectal cancer. Imaging Science and Photochemistry. 2021;39:479\u201382.","journal-title":"Imaging Science and Photochemistry."}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-021-02448-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-021-02448-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-021-02448-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T07:03:56Z","timestamp":1639033436000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-021-02448-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2448"],"URL":"https:\/\/doi.org\/10.1186\/s12957-021-02448-3","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"29 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is approved by the ethics committee of Affiliated Yantai Yuhuangding Hospital of Qingdao University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"343"}}